• JG

Study on VeraForm® Presented at 38th Annual Miami Breast Conference

Updated: Mar 9

50-patient registry study presented by Sunny Mitchell, M.D. highlights ease of use and applicability of the VeraForm® marker in lumpectomy









The Miami Breast Cancer Conference is an annual meeting that brings together multidisciplinary groups of physicians involved in various aspects of breast cancer treatment. At this year's meeting, Dr. Sunny Mitchell presented a registry study that captured the placement of the VeraForm adaptable tissue marker in 50 consecutive patients undergoing breast conserving surgery for DCIS or invasive cancer and the analysis evaluated patient, breast and surgical characteristics.


The following abstract details the findings of placing VeraForm in these patients which was used exclusively to delineate the tumor bed. Some of the highlights include:

- VeraForm was adaptable to a wide range and variety of breast conserving surgeries

- placed in a wide range of incisions

- There were no adverse effects such as pain or infections

- VeraForm placement was in 2 minutes or less on average

- VeraForm was non-palpable and had no adverse effects on cosmetic results





165 views0 comments

Recent Posts

See All

Designing an Optimal Breast Cancer Radiation Protocol

How a Novel Tissue Marker Makes a Difference Chirag Shah, MD and Zahraa Al-Hilli, MD at the Cleveland Clinic discuss partial breast irradiation (PBI) and the impact of placing the VeraForm® marker for